| scholarly article | Q13442814 |
| P50 | author | Mark A. Little | Q37373578 |
| P2093 | author name string | Dupont P | |
| Campbell E | |||
| Dorman A | |||
| Walshe JJ | |||
| P2860 | cites work | Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989 | Q68761162 |
| Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases | Q68854964 | ||
| Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Pädiatrische Nephrologie | Q71229273 | ||
| Low prevalence of hepatitis C virus antibodies with primary membranous nephropathy and membranoproliferative glomerulonephritis in Hong Kong | Q71524543 | ||
| Idiopathic membranoproliferative glomerulonephritis in Japanese children | Q71951422 | ||
| Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys | Q73353458 | ||
| Renal transplantation in patients with dense deposit disease: morphological characteristics of recurrent disease and clinical outcome | Q78094528 | ||
| High prevalence of hepatitis C virus antibodies in older patients with membranoproliferative glomerulonephritis | Q78136039 | ||
| Familial membranoproliferative glomerulonephritis type III | Q28207671 | ||
| Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1 | Q28215804 | ||
| Mesangiocapillary glomerulonephritis: A long-term study of 40 cases | Q28266827 | ||
| Management of membranoproliferative glomerulonephritis: evidence-based recommendations | Q33658806 | ||
| Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection | Q34058506 | ||
| Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis | Q40144637 | ||
| Recurrent diseases in the kidney transplant | Q40667646 | ||
| Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus | Q43035291 | ||
| A comprehensive study of the association between hepatitis C virus and glomerulopathy | Q43036374 | ||
| Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children | Q44053843 | ||
| The pathogenesis of membranoproliferative glomerulonephritis in KwaZulu-Natal, South Africa is unrelated to hepatitis C virus infection | Q45722089 | ||
| Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience | Q46486094 | ||
| Long-term prognosis in idiopathic membranoproliferative glomerulonephritis. | Q51039813 | ||
| Mesangioproliferative glomerulonephritis with IgM deposition: clinical characteristics and outcome. | Q54044001 | ||
| Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis | Q61388032 | ||
| Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis | Q67244708 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 504-511 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk | |
| P478 | volume | 69 |
| Q37193631 | A primer on recurrent and de novo glomerulonephritis in renal allografts |
| Q56908029 | Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies |
| Q37426966 | C3 glomerulopathy: clinicopathologic features and predictors of outcome |
| Q37348685 | C3 glomerulopathy: consensus report |
| Q42246527 | C3 nephritic factor associated with C3 glomerulopathy in children |
| Q41485811 | Case Report of Spontaneous Remission of Biopsy-Proven Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis |
| Q35580577 | Clinical features and outcomes of 98 children and adults with dense deposit disease. |
| Q26829790 | Complement cascade and kidney transplantation: The rediscovery of an ancient enemy |
| Q35567841 | Complement involvement in kidney diseases: From physiopathology to therapeutical targeting |
| Q37522557 | Complement related kidney diseases: Recurrence after transplantation |
| Q58120548 | Complement-mediated renal diseases after kidney transplantation - current diagnostic and therapeutic options in and recurrent diseases |
| Q38843499 | Current status of pediatric renal transplant pathology |
| Q26860761 | De novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literature |
| Q37286653 | Dense deposit disease and C3 glomerulopathy |
| Q33381183 | Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients |
| Q79196477 | Differences between type I and II membranoproliferative glomerulonephritis |
| Q38275117 | Histopathology of MPGN and C3 glomerulopathies |
| Q42749819 | Kidney transplant outcomes in familial C3 glomerulopathy |
| Q100697445 | Kidney transplantation for primary glomerulonephritis: Recurrence risk and graft outcomes with related versus unrelated donors |
| Q55240851 | Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause. |
| Q41087203 | Mycophenolate mofetil as a possible therapeutic option for idiopathic membranoproliferative glomerulonephritis |
| Q44886223 | Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis |
| Q38445275 | Primary disease recurrence—effects on paediatric renal transplantation outcomes |
| Q37146427 | Probability, predictors, and prognosis of posttransplantation glomerulonephritis |
| Q43086742 | Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study |
| Q26741542 | Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN |
| Q38129623 | Recurrence of glomerulonephritis after renal transplantation. |
| Q36580726 | Recurrent glomerulonephritis after kidney transplantation. |
| Q37084056 | Recurrent glomerulonephritis after renal transplantation: an unsolved problem |
| Q82978817 | Recurrent membranoproliferative glomerulonephritis after second renal graft treated with plasmapheresis and rituximab |
| Q38749694 | Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies |
| Q51033762 | Selection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation. |
| Q33377727 | Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis |
| Q38880897 | Understanding the complement-mediated glomerular diseases: focus on membranoproliferative glomerulonephritis and C3 glomerulopathies |
| Q33403607 | Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies |
Search more.